Robert G. Jr. Spignesi Sells 11,247 Shares of Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Stock

Rapid Micro Biosystems, Inc. (NASDAQ:RPID - Get Free Report) CEO Robert G. Jr. Spignesi sold 11,247 shares of Rapid Micro Biosystems stock in a transaction on Wednesday, July 9th. The shares were sold at an average price of $3.51, for a total transaction of $39,476.97. Following the transaction, the chief executive officer owned 900,583 shares in the company, valued at approximately $3,161,046.33. This trade represents a 1.23% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.

Rapid Micro Biosystems Trading Down 0.3%

Shares of RPID traded down $0.01 during trading hours on Friday, reaching $3.36. 58,625 shares of the stock traded hands, compared to its average volume of 197,773. Rapid Micro Biosystems, Inc. has a 52-week low of $0.64 and a 52-week high of $4.04. The company's 50-day moving average price is $3.31 and its two-hundred day moving average price is $2.59. The company has a market cap of $147.28 million, a P/E ratio of -3.26 and a beta of 1.32.

Rapid Micro Biosystems (NASDAQ:RPID - Get Free Report) last released its earnings results on Friday, May 9th. The company reported ($0.26) earnings per share for the quarter, beating analysts' consensus estimates of ($0.27) by $0.01. The company had revenue of $7.21 million for the quarter, compared to analysts' expectations of $6.63 million. Rapid Micro Biosystems had a negative net margin of 151.22% and a negative return on equity of 56.07%. On average, research analysts forecast that Rapid Micro Biosystems, Inc. will post -1.1 EPS for the current year.

Institutional Trading of Rapid Micro Biosystems

Several hedge funds have recently bought and sold shares of RPID. American Century Companies Inc. purchased a new stake in Rapid Micro Biosystems in the 1st quarter worth $31,000. Legato Capital Management LLC purchased a new stake in Rapid Micro Biosystems in the 1st quarter worth $41,000. Millennium Management LLC lifted its stake in Rapid Micro Biosystems by 17.6% in the 4th quarter. Millennium Management LLC now owns 61,375 shares of the company's stock worth $55,000 after purchasing an additional 9,191 shares in the last quarter. Citadel Advisors LLC purchased a new stake in Rapid Micro Biosystems in the 4th quarter worth $65,000. Finally, Renaissance Technologies LLC lifted its stake in Rapid Micro Biosystems by 122.9% in the 4th quarter. Renaissance Technologies LLC now owns 183,087 shares of the company's stock worth $165,000 after purchasing an additional 100,942 shares in the last quarter. Hedge funds and other institutional investors own 52.60% of the company's stock.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.